Searched for
IPCA LABS STOCK
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian indices were subdued with Nifty up 0.03% and Sensex down 0.10%. High volatility (VIX at 19.63) and bearish momentum indicators sugge...
- Gland Pharma,6 stocks hit 52-week highs, rally up to 20% in a monthDespite a marginal rise in the Sensex, seven BSE 500 stocks touched fresh 52-week highs, signalling strong bullish momentum. Gland Pharma, ...
- Mutual funds cut technology sector exposure to 8-year low in April. Is AI disruption reshaping sentiment?Mutual funds have significantly reduced their technology sector exposure to an eight-year low, driven by concerns over AI disruption, slowi...
- Jio Financial, ITC Hotels and Manappuram Finance among stocks bought and sold by mutual funds in AprilMutual funds injected Rs 30,600 crore into Indian equities in April, with significant buying in ICICI Bank, SBI, and Sun Pharma. Key reduct...
- Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocksThe US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...
- Reduce Ipca Labs, target price Rs 1,250: Prabhudas LilladherIpca Labs (IPCA) Q1 EBITDA of Rs 3.9 bn was in line with our estimate. Management guidance of 9% revenue growth (excluding Unichem) was bel...
- F&O Radar | Deploy Debit Spread in Ipca Labs to play potential upward rallyIpca Laboratories' stock price traded within a range around the Rs 1,360 level during April and May. However, it subsequently trended downw...
- Ipca Labs falls 3% after USFDA issues Form 483 to API unitShares of Indian pharmaceutical company, Ipca Laboratories, fell by 3% after the US Food and Drug Administration (USFDA) issued a Form 483 ...
- Ipca Labs shares tumble 9% on acquisition of stake in Unichem LaboratoriesIpca Laboratories has agreed to buy 33.38% of the paid-up equity share capital of Unichem Laboratories for INR1,034.06 crore ($160m). The a...
- Chart Check: Ipca Laboratories gives a breakout from a falling trend line resistance; time to buy?Ipca Laboratories, a pharma company, is a potential buy as it has recorded a breakout from a falling trendline resistance and a Cup & Handl...
- Ipca Labs shares drop over 5% on weak Q3 results. What should investors do?EBITDA before forex declined 15% to Rs 262.82 crore in the third quarter of 2022 from Rs 310.83 crore posted in the same quarter of FY22. E...
- Buy Ipca Laboratories, target price Rs 930: EdelweissIpca Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Export Incentives, Sale of services ...
- This drug maker, 40% owned by MF & FPIs, just had a weak Q2. Time to sell?The scrip has been a favourite of mutual funds and FPIs, who owned over 40 per cent stake in the drug maker, with promoters holding another...
- Exit Ipca Labs; it's the next Wockhardt in making: Dipan MehtaInvestors have to try and manage risks by buying into a basket of midcap pharma stocks, which is what we have been advising over the years,...
- Going short in Ipca Labs would be risky: Deepak MohoniIpca Labs has certainly run up but going short in a stock that is running up especially in a market which is not particularly strong, that ...
- Ipca Labs among the better performing pharma stocks: Deepak MohoniIt has had a very good bull market. It has been in a persistent rally.
- Ipca Laboratories outperformers in pharma space: Sharmila JoshiSharmila Joshi, Co Head PCG Sales, Emkay Global Financial Services spoke to ET Now on Ipca Labs.
- Limited upside seen for Ipca LabsAlong with current stock valuations, there seems to be a limited upside to the company’s stock price. New investors would be better off avo...
Load More
